{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:56:05Z","timestamp":1649195765190},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00292-020-00863-z","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T09:02:55Z","timestamp":1606986175000},"page":"143-148","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Routinem\u00e4\u00dfige zielgerichtete Hochdurchsatzsequenzierung von lymphoproliferativen Erkrankungen"],"prefix":"10.1007","volume":"41","author":[{"given":"T.","family":"Menter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dirnhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"issue":"4","key":"863_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00292-020-00793-w","volume":"41","author":"B Sobottka","year":"2020","unstructured":"Sobottka\u00a0B, Weber\u00a0A (2020) Molecular tumor diagnostics-current methods, examples of application and future. Pathologe 41(4):411\u2013424","journal-title":"Pathologe"},{"issue":"12","key":"863_CR2","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-15-2305","volume":"22","author":"S Dubois","year":"2016","unstructured":"Dubois\u00a0S, Viailly\u00a0PJ, Mareschal\u00a0S, Bohers\u00a0E, Bertrand\u00a0P, Ruminy\u00a0P et al (2016) Next-generation sequencing in diffuse large B\u2011cell lymphoma highlights molecular divergence and therapeutic opportunities: a\u00a0LYSA study. Clin Cancer Res 22(12):2919\u20132928","journal-title":"Clin Cancer Res"},{"issue":"12","key":"863_CR3","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1038\/leu.2016.135","volume":"30","author":"D Juskevicius","year":"2016","unstructured":"Juskevicius\u00a0D, Lorber\u00a0T, Gsponer\u00a0J, Perrina\u00a0V, Ruiz\u00a0C, Stenner-Liewen\u00a0F et al (2016) Distinct genetic evolution patterns of relapsing diffuse large B\u2011cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. Leukemia 30(12):2385\u20132395","journal-title":"Leukemia"},{"issue":"284","key":"863_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/hon.2718","volume":"38","author":"V Vela","year":"2020","unstructured":"Vela\u00a0V, Juskevicius\u00a0D, Gerlach\u00a0MM, Meyer\u00a0P, Graber\u00a0A, Cathomas\u00a0G et al (2020) High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B\u2011cell lymphomas. Hematol Oncol 38(284):292. https:\/\/doi.org\/10.1002\/hon.2718","journal-title":"Hematol Oncol"},{"issue":"1","key":"863_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-017-0438-7","volume":"10","author":"D Juskevicius","year":"2017","unstructured":"Juskevicius\u00a0D, Jucker\u00a0D, Klingbiel\u00a0D, Mamot\u00a0C, Dirnhofer\u00a0S, Tzankov\u00a0A (2017) Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38\/07 prospective clinical trial cohort. J\u00a0Hematol Oncol 10(1):70","journal-title":"J Hematol Oncol"},{"issue":"1","key":"863_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/bjh.14633","volume":"178","author":"T Menter","year":"2017","unstructured":"Menter\u00a0T, Juskevicius\u00a0D, Alikian\u00a0M, Steiger\u00a0J, Dirnhofer\u00a0S, Tzankov\u00a0A et al (2017) Mutational landscape of B\u2011cell post-transplant lymphoproliferative disorders. Br J Haematol 178(1):48\u201356","journal-title":"Br J Haematol"},{"issue":"7","key":"863_CR7","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1080\/10428194.2017.1387903","volume":"59","author":"D Juskevicius","year":"2018","unstructured":"Juskevicius\u00a0D, M\u00fcller\u00a0A, Hashwah\u00a0H, Lundberg\u00a0P, Tzankov\u00a0A, Menter\u00a0T (2018) Characterization of the mutational profile of 11 diffuse large B\u2011cell lymphoma cell lines. Leuk Lymphoma 59(7):1710\u20131716","journal-title":"Leuk Lymphoma"},{"key":"863_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1786560","author":"V Pillonel","year":"2020","unstructured":"Pillonel\u00a0V, Juskevicius\u00a0D, Bihl\u00a0M, Stenner\u00a0F, Halter\u00a0JP, Dirnhofer\u00a0S et al (2020) Routine next generation sequencing of lymphoid malignancies: clinical utility and challenges from a 3\u2011year practical experience. Leuk Lymphoma. https:\/\/doi.org\/10.1080\/10428194.2020.1786560","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"863_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/PAS.0000000000000120","volume":"38","author":"D Juskevicius","year":"2014","unstructured":"Juskevicius\u00a0D, Ruiz\u00a0C, Dirnhofer\u00a0S, Tzankov\u00a0A (2014) Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B\u2011cell lymphomas with CYCLIN D1 gene rearrangements. Am J Surg Pathol 38(5):719\u2013727","journal-title":"Am J Surg Pathol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00863-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-020-00863-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00863-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T07:12:28Z","timestamp":1611213148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-020-00863-z"}},"subtitle":["Klinischer Nutzen und Herausforderungen"],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":9,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["863"],"URL":"https:\/\/doi.org\/10.1007\/s00292-020-00863-z","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"3 December 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Menter, S.\u00a0Dirnhofer und A.\u00a0Tzankov geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}